-
Clinical Ophthalmology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Aqueous humor and serum penetration of tacrolimus after topical and oral administration in rats: an absorption study
(2421) Views (526) Full article downloads
Authors: F Nilüfer Yalçindag, Figen Batioglu, Nuray Ari, Özden Özdemir
Published Date June 2007
Volume 2007:1(1) Pages 61 - 64
DOI: http://dx.doi.org/10.2147/OPTH.S
F Nilüfer Yalçindag1, Figen Batioglu1, Nuray Ari2, Özden Özdemir1
1Ankara University Faculty of Medicine Ophthalmology Department; 2Ankara University Faculty of Pharmacy Pharmacology Department, Ankara, Turkey
Purpose: To investigate the penetration of tacrolimus to the aqueous and serum after topical and oral administration.
Methods: Thirty Wistar rats were divided into three groups. In the first group (n = 12), a single dose of 0.3 % isotonic tacrolimus solution was applied topically to the rat eyes. The second group (n = 12), received 0.1 mg/kg/day tacrolimus for three days. In control group (n = 6), the rats were administered a single drop of 0.3% salin solution topically. Following collection of samples, the amounts of tacrolimus in aqueous and serum samples were compared with each other.
Results: In group I, the mean concentration of tacrolimus was 35.16 ng/ml in aqueous and 2.22 ng/ml in serum. In group II, the mean concentration of tacrolimus was 13.08 ng/ml in aqueous and 13.45 ng/ml in serum. There was no significant difference in the serum concentration levels of tacrolimus between group I and control group. However there was a significant difference of the drug concentrations in aqueous between the groups (p < 0.001). The mean aqueous and serum concentrations of tacrolimus in group II, differed significantly from the mean concentrations in group I (p < 0.001) and the control group (p < 0.001).
Conclusion: Tacrolimus may be a promising treatment modality in intraocular inflammation by topical application besides systemic administration.
Keywords: FK506, humor aqueous, tacrolimus, penetration into the eye, systemic application, topical application
Readers of this article also read:
Randomized trial of superficial peribulbar compared with conventional peribulbar anesthesia for cataract extraction
Possible influences of lutein and zeaxanthin on the developing retina
Effect of audible and visual reminders on adherence in glaucoma patients using a commercially available dosing aid
Hypoxia-ischemia and retinal ganglion cell damage
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
Corrigendum
Erratum
- Journal Indexing
See where all the Dove Press journals are indexed
- Interested in being a peer-reviewer?
Click here to register.
- Insight into 144 patients with ocular vascular events during VEGF antagonist injections
- Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives
- Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
- A computer-based anaglyphic system for the treatment of amblyopia




